We then further analyzed by flow cytometry monocyte/NEC or TEC cocultures, and particularly the CD31−CD45+ cell fraction for pro-tumor M2-like (CD163) and anti-tumor M1-like (HLA-DR) macrophage markers. The gene discussed is CD163; the disease is neoplasm.